Form 8-K Allarity Therapeutics, For: Mar 19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Allarity Therapeutics (ALLR) Enters ATM Agreement
March 20, 2024 6:08 AM EDTOn March 19, 2024, Allarity Therapeutics (NASDAQ: ALLR), entered into an At-The-Market Issuance Sales Agreement (the Agreement) with Ascendiant Capital Markets, LLC (the Agent), pursuant to which the Company may offer and sell, from time to time, through the Agent, shares (the Placement Shares) of the Companys common stock, par value $0.0001 per share, having an aggregate offering price of up to $947,000, subject to the terms and conditions of the Agreement. The Placement Shares will be offered and sold pursuant to the Companys prospectus supplement (the Prospectus Supplement), filed March 19, 2024 with the Securities and Exchange Commission (the Commission), to the... More
